Search results
Alligator Bioscience's Phase 2 mitazalimab Pancreatic Cancer Data Published in The Lancet Oncology
Morningstar· 6 days agoLUND, SE / ACCESSWIRE / June 03, 2024 / Alligator Bioscience (STO:ATORX)Publication in world-leading clinical oncology journal validates the quality and potential implications ...
Analysts’ Weekly Ratings Updates for Aptose Biosciences (APTO)
ETF DAILY NEWS· 3 days ago6/6/2024 – Aptose Biosciences is now covered by analysts at StockNews.com. 5/29/2024 – Aptose Biosciences is now covered by analysts at StockNews.com. 5 ...
Investment Analysts’ Weekly Ratings Changes for Solid Biosciences (SLDB)
ETF DAILY NEWS· 5 days ago5/31/2024 – Solid Biosciences is now covered by analysts at Piper Sandler. 5/31/2024 – Solid Biosciences had its price target lowered by analysts at JPMorgan ...
Evercore ISI downgrades Caribou Biosciences stock amid strategic challenges By Investing.com
Investing.com· 6 days agoOn Monday, Evercore ISI adjusted its stance on Caribou Biosciences Inc. (NASDAQ:CRBU), downgrading...
Citi maintains 'Buy' on Arcus Biosciences stock, cites promising trial results By Investing.com
Investing.com· 6 days agoOn Monday, Citi maintained a Buy rating on Arcus Biosciences (NYSE:RCUS) stock and increased the...
Oppenheimer cuts Ventyx Biosciences stock target, holds Outperform rating By Investing.com
Investing.com· 3 days agoOppenheimer cuts Ventyx Biosciences stock target, holds Outperform rating
Cogent Biosciences Inc (NASDAQ: COGT) Could Bring Massive Returns? – Marketing Sentinel
Marketing Sentinel· 6 days agoIn the last trading session, 1.38 million shares of the Cogent Biosciences Inc (NASDAQ:COGT) were traded, and its beta was 1.59. Most recently the company’s share price was ...
What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences...
Benzinga via Yahoo Finance· 3 days agoOn Wednesday, the stocks of Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) and Sagimet Biosciences Inc...
Treasurer of the State of North Carolina Increases Position in Neurocrine Biosciences, Inc....
ETF DAILY NEWS· 7 days agoTreasurer of the State of North Carolina boosted its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 0.8% during the fourth quarter, according ...
Wall Street Analysts See a 162.63% Upside in Aura Biosciences (AURA): Can the Stock Really Move This...
Zacks via Yahoo Finance· 3 days agoThe mean of analysts' price targets for Aura Biosciences (AURA) points to a 162.6% upside in the...